The Association of the British Pharmaceutical Industry (ABPI) has said that it wants to take transparency to the next level, and has committed to making clinical research more accessible and understandable across the pharmaceutical industry.
The latest scoop from Evidence-Based Medicine Live
Evidence is essential for identifying treatment priorities and developing polices, said Claire Allen of Evidence Aid, at Evidence-Based Medicine Live (EBMLive), which took place on 15–17 July in Oxford, UK.
Research discoverability – insights from the OAI 11 CERN-UNIGE Workshop on Innovations in Scholarly Communication
When it comes to driving change in academic publishing practices, much of the focus is on making research outputs freely available to all those who wish to access them. However, open access publishing is just the tip of the iceberg.
Clinical trial transparency – who’s watching?
On 15 May 2019, the Center for Biomedical Research Transparency (CBMRT) brought the stakeholders in academic publishing together to share their varying perspectives on research transparency and accessibility at the European Biomedical Transparency Summit (BMTS), in Paris.
Weekly digest: what’s happening in open science?
Featuring the release of the latest European University Association Open Access Survey results, the ordering of a predatory publisher to pay millions of dollars for deception, the adoption of Creative Commons licences by the European Commission and the launch of PeerJ-SciHub.
New Open Pharma resource: open access educational materials
New Open Pharma resource: open access educational materials
Using metadata to make open access science discoverable
In January 2019, Open Pharma core members and supporters attended a roundtable meeting, hosted by The BMJ at its Head Office at BMA House in London.
ISMPP U webinar: insights and perspectives on open access in medical publishing
Last week’s ISMPP-U webinar ‘Open Access and Medical Publishing’, developed by the Medical Publishing Insights & Practices (MPIP) initiative and Open Pharma and moderated by LaVerne Mooney (Pfizer) and Chris Winchester (Oxford PharmaGenesis), aimed to define the key elements of open access policies, to provide insight into the changing publishing environment and to understand the perspectives of non-commercial and commercial stakeholders on open access publishing.
MPIP launches new open access toolkit
A new reference site from Medical Publishing Insights and Practices (MPIP) aims to educate its users on the ins and outs of open access as part of its commitment to improving research transparency in pharma. With open access everywhere nowadays, it is very important to know what it is and how it works. However, this … Continue reading MPIP launches new open access toolkit
Weekly digest: what’s happening in open science?
Featuring how libraries can support Plan S implementation, the Incentivization Blueprint encouraging funders to align with the principles of open research, and the effect on citation performance of a journal becoming open access.